These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16234895)

  • 21. Management of atrial fibrillation in heart failure in the elderly.
    Abi Nasr I; Mansencal N; Dubourg O
    Int J Cardiol; 2008 Apr; 125(2):178-82. PubMed ID: 18029038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.
    Talajic M; Roy D
    Can J Cardiol; 2005 Sep; 21 Suppl B():19B-25B. PubMed ID: 16239983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation in heart failure: the chicken or the egg?
    Balasubramaniam R; Kistler PM
    Heart; 2009 Apr; 95(7):535-9. PubMed ID: 18632835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of atrial fibrillation: rhythm control or heart rate correction?].
    Stellbrink Ch
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S108-12. PubMed ID: 16921446
    [No Abstract]   [Full Text] [Related]  

  • 26. New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?
    Morrow JP; Cannon CP; Reiffel JA
    Am Heart J; 2007 Nov; 154(5):824-9. PubMed ID: 17967585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Atrial fibrillation: current therapeutic options].
    Lüderitz B
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():147-9. PubMed ID: 16802541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation.
    Wongcharoen W; Chen SA
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):311-22. PubMed ID: 19296769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shedding new light on the pathophysiology of conversion of paroxysmal atrial fibrillation into persistent atrial fibrillation.
    Homoud MK; Estes M
    Am Heart J; 2007 Nov; 154(5):801-4. PubMed ID: 17967581
    [No Abstract]   [Full Text] [Related]  

  • 30. Atrial fibrillation. Preface.
    Oral H
    Cardiol Clin; 2014 Nov; 32(4):xi-xii. PubMed ID: 25443243
    [No Abstract]   [Full Text] [Related]  

  • 31. [Restoration and maintenance of sinus rhythm in patients with atrial fibrillation. New pharmacological approaches].
    Runge S; Dietz R; Haverkamp W
    Dtsch Med Wochenschr; 2008 Dec; 133(49):2572-8. PubMed ID: 19039713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New concepts in the therapy of atrial fibrillation.
    Cocco G; Jerie P
    Cardiol J; 2016; 23(1):3-11. PubMed ID: 26412599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
    Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rate control vs rhythm control strategies in atrial fibrillation.
    Wyse DG
    Prog Cardiovasc Dis; 2005; 48(2):125-38. PubMed ID: 16253652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New onset of atrial fibrillation--rate or rhythm control?].
    Lewalter T
    MMW Fortschr Med; 2009 Apr; 151(16):29, 31-2. PubMed ID: 19658292
    [No Abstract]   [Full Text] [Related]  

  • 36. A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.
    Waldo AL
    Am Heart J; 2006 Apr; 151(4):771-8. PubMed ID: 16569531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rhythm control as treatment for patients with medication-resistant atrial fibrillation: maze surgery and percutaneous pulmonary vein isolation by catheter ablation].
    van Gelder IC
    Ned Tijdschr Geneeskd; 2006 Oct; 150(42):2294-6. PubMed ID: 17089544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
    Wyse DG
    Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Catheter ablation of chronic atrial fibrillation using circumferential and complex linear lesions in the left atrium: modes of arrhythmia termination and long-term clinical outcome].
    Fiala M; Chovancík J; Neuwirth R; Nevralová R; Jiravský O; Szymeczek H; Wojnarová D; Moravec R; Sknouril L; Dorda M; Januska J; Nykl I; Cerný J; Branny M
    Vnitr Lek; 2007 Mar; 53(3):231-41. PubMed ID: 17503636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The substrate maintaining persistent atrial fibrillation.
    Haïssaguerre M; Wright M; Hocini M; Jaïs P
    Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):2-5. PubMed ID: 19808387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.